 Home > Active Ingredient News > Study of Nervous System > The Lancet published a China study that will rapidly impact stroke treatment worldwide

The Lancet published a China study that will rapidly impact stroke treatment worldwide

 Last Update: 2022-11-05
 Source: Internet
 Author: User

Tags

cookie world seat

benefits gene therapy

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

*For medical professionals only

Combined with various previous studies, it is clear that it is not advisable
to strengthen the antihypertensive scheme.

Written by | Ling Jun
ON OCTOBER 28, THE LANCET, A TOP MEDICAL JOURNAL, RELEASED ONLINE THE RESULTS OF THE FIRST PHASE OF THE STUDY OF "INTENSIVE ANTIHYPERTENSIVE THERAPY AFTER MECHANICAL THROMBECTOMY OF ACUTE ISCHEMIC STROKE" (ENCHANTED-2/MT), WHICH WAS PRESENTED BY CO-PRINCIPAL INVESTIGATOR PROFESSOR CRAIG ANDERSON AT THE 14TH WORLD STROKE CONGRESS ON THE SAME DAY (14th World Stroke Congress) was announced to the world and caused a sensation in the academic community at home and abroad
.

The study, co-led by a team of Chinese and Australian scholars, found that the clinical prognosis of patients in the intensive antihypertensive therapy (systolic blood pressure <120mmHg)</b110> Dr.
Lili Song, director of the stroke program at The George Institute for Global Health (

Click "Read Original" for more information

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Quality Pregabalin 99% powder 148553-50-8 -Shaanxi Dideu Medichem Co.Ltd

CAS No.: 148553-50-8

Chemical Grade

$1/KG FOB

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.